BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 14222418)

  • 1. ELECTROLYTE EXCRETION BY SWEAT GLANDS AND KIDNEYS DURING SUPPRESSION OF ADRENAL CORTICOSTEROID ACTIVITY BY METHOPYRAPONE AND SPIRONOLACTONE.
    MAY CD
    Am J Dis Child; 1965 Jan; 109():2-8. PubMed ID: 14222418
    [No Abstract]   [Full Text] [Related]  

  • 2. THE EFFECT OF A SALT LOAD AND ALDOSTERONE ON THE ACID-BASE-EQUILIBRIUM AND ON THE ELECTROLYTES IN BLOOD AND URINE OF NORMAL SUBJECTS FOLLOWING CHEMICAL BLOCKADE OF THE ADRENAL CORTEX.
    MARTINI O; VOIGT KD; TAMM J; DOELLE W
    Acta Endocrinol (Copenh); 1964 Dec; 47():619-32. PubMed ID: 14253886
    [No Abstract]   [Full Text] [Related]  

  • 3. [EFFECT OF A SPIRONOLACTONE ALDOSTERONE INHIBITOR AND CHLOROTHIAZIDE ON WATER AND ELECTROLYTE EXCRETION IN LIVER DISEASES].
    PERISIC V; KONECNI J; BANICEVIC B
    Srp Arh Celok Lek; 1964 Mar; 92():301-8. PubMed ID: 14242671
    [No Abstract]   [Full Text] [Related]  

  • 4. EFFECT OF AN ALDOSTERONE ANTAGONIST ON ELECTROLYTES AND JUXTAGLOMERULAR GRANULARITY IN ADRENAL REGENERATION HYPERTENSION.
    RAPP JP
    Endocrinology; 1964 Sep; 75():326-32. PubMed ID: 14235399
    [No Abstract]   [Full Text] [Related]  

  • 5. THE SU-4885 (METHOPYRAPONE) RESPONSE AFTER HEAD INJURY.
    MCCARTHY CF; WILLS MR; KEANE PM; GOUGH KR; READ AE
    J Clin Endocrinol Metab; 1964 Jan; 24():121-4. PubMed ID: 14112237
    [No Abstract]   [Full Text] [Related]  

  • 6. [PATHOPHYSIOLOGY AND CLINICAL ASPECTS OF SECONDARY ALDOSTERONISM AND ITS TREATMENT].
    HOFFMEISTER W
    Folia Clin Int (Barc); 1964 Mar; 14():124-44. PubMed ID: 14153959
    [No Abstract]   [Full Text] [Related]  

  • 7. [ON THE DIURETIC EFFECT OF THE ADRENOSTATIC DRUG METHOPYRAPONE].
    HIERHOLZER K
    Dtsch Med Wochenschr; 1964 Jun; 89():1124-7. PubMed ID: 14152369
    [No Abstract]   [Full Text] [Related]  

  • 8. D-ALDOSTERONE AND SWEAT ELECTROLYTES.
    MCCONAHAY TP; ROBINSON S; NEWTON JL
    J Appl Physiol; 1964 Jul; 19():575-9. PubMed ID: 14195564
    [No Abstract]   [Full Text] [Related]  

  • 9. [ON MODIFICATIONS OF PLASMA AND URINARY ELECTROLYTES IN ASCITOGENIC HEPATIC CIRRHOSIS IN TREATMENT WITH TRIAMTERENE ALONE AND ASSOCIATED WITH HYDROCHLOROTHIAZIDE AND WITH SPIRONOLACTONE].
    MELLONI GF; BARATTA C; MARANGONI R; MERLO L; ANTOGNETTI R
    Minerva Med; 1964 Sep; 55():2722-37. PubMed ID: 14199461
    [No Abstract]   [Full Text] [Related]  

  • 10. ALDOSTERONE IN THE MAINTENANCE OF THE WATER-ELECTROLYTE BALANCE.
    GIBINSKI K; KOKOT F; NOWAK S; GIEC L
    Acta Med Pol; 1963; 4():321-8. PubMed ID: 14104743
    [No Abstract]   [Full Text] [Related]  

  • 11. USE OF METHOPYRAPONE (SU-4885) IN THE STUDY OF PITUITARY-ADRENAL RESPONSE IN PATIENTS UNDER CORTICOSTEROID TREATMENT.
    JANCHES M; GOLDBERG V; SEGALL ; JAIMOVICH L; CATOGGIO P; DELABALZE FA
    J Clin Endocrinol Metab; 1965 Apr; 25():534-9. PubMed ID: 14277389
    [No Abstract]   [Full Text] [Related]  

  • 12. DETERMINATION OF ANTIALDOSTERONE ACTIVITY IN NORMAL DOGS.
    ROSENTHALE ME; SCHNEIDER F; KASSARICH J; DATKO L
    Proc Soc Exp Biol Med; 1965 Mar; 118():806-9. PubMed ID: 14264565
    [No Abstract]   [Full Text] [Related]  

  • 13. FURTHER NOTES ON THE INTERACTION OF SPIRONOLACTONE AND DEOXYCORTICOSTERONE ACETATE IN DOGS.
    KAGAWA CM; BOUSKA DJ; ANDERSON ML
    Acta Endocrinol (Copenh); 1964 Jan; 45():79-83. PubMed ID: 14102672
    [No Abstract]   [Full Text] [Related]  

  • 14. EFFECT OF SWEAT LOSS ON BODY FLUIDS.
    KOZLOWSKI S; SALTIN B
    J Appl Physiol; 1964 Nov; 19():1119-24. PubMed ID: 14232306
    [No Abstract]   [Full Text] [Related]  

  • 15. MODIFICATION OF ALDOSTERONE SECRETION AND ELECTROLYTE EXCRETION IN MAN BY A CHEMICAL INHIBITOR OF 18-OXIDATION.
    BLEDSOE T; ISLAND DP; RIONDEL AM; LIDDLE GW
    J Clin Endocrinol Metab; 1964 Aug; 24():740-6. PubMed ID: 14202753
    [No Abstract]   [Full Text] [Related]  

  • 16. [THE INCRETORY DYNAMICS OF THE ADRENAL CORTEX IN ACROMEGALY].
    MONTERVINO C; MARINOSCI A; DONATI L; NUZZI R; IACOBELLI A
    Folia Endocrinol; 1964 Aug; 17():452-67. PubMed ID: 14233063
    [No Abstract]   [Full Text] [Related]  

  • 17. EFFECT OF AN ALDOSTERONE ANTAGONIST (SPIRONOLACTONE) ON PATIENTS WITH SEVERE CONGESTIVE HEART FAILURE.
    CARRUTHERS BM; LEDRAY RD; SERAGLIA M; MCINTOSH HW; WALSH GC
    Can Med Assoc J; 1963 Sep; 89(13):633-41. PubMed ID: 14077808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPIROLACTONE EFFECT ON POSTOPERATIVE ELECTROLYTES AND ADRENAL ACTIVITY.
    SELLER RH; RAMIREZ-MUXO O; SWARTZ C; PITHA N; BREST AN
    JAMA; 1963 Dec; 186():994-8. PubMed ID: 14066723
    [No Abstract]   [Full Text] [Related]  

  • 19. [CONTRIBUTION TO THE PROBLEM OF IDIOPATHIC EDEMA].
    BOEHM P; FRANKEN FH; IRMSCHER K
    Klin Wochenschr; 1963 Dec; 41():1155-61. PubMed ID: 14114041
    [No Abstract]   [Full Text] [Related]  

  • 20. RESPONSE OF CHILDREN TO METHOPYRAPONE (METOPIRONE).
    RICHMOND L; CHAPPELL J; CLEVELAND WW
    J Pediatr; 1964 Mar; 64():381-6. PubMed ID: 14130711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.